EGB Stock Chart & Stats
€170.50
€2.00(1.61%)
At close: 4:00 PM EST
€170.50
€2.00(1.61%)
Day’s Range― - ―
52-Week Range€116.00 - €184.00
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€8.75B
Enterprise Value€13.66K
Total Cash (Recent Filing)€595.17M
Total Debt (Recent Filing)€2.24B
Price to Earnings (P/E)26.7
Beta-0.04
Next Earnings
Jul 23, 2026EPS Estimate
1.62Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.33
Shares Outstanding58,445,400
10 Day Avg. Volume5
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)4.47
Price to Sales (P/S)1.97
P/FCF Ratio26.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€189.07Price Target Upside10.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)6.61
Revenue Forecast (FY)€5.11B
Bulls Say, Bears Say
Bulls Say
Record Occupancy And Improving CensusSustained record occupancy and rising skilled census improve revenue stability and payer mix over months. Higher occupancy increases fixed-cost absorption, supports therapy utilization and Medicare/managed-care revenue, underpinning durable top-line and margin recovery as volumes remain elevated.
Accelerating M&A And Portfolio GrowthActive, repeatable M&A expands scale, market position and referral networks across high-growth markets. A steady pipeline of integrations increases revenue base and offers operating leverage opportunities if Ensign sustains quality-driven turnarounds and standardized playbooks across acquired assets.
Strong Liquidity And Improving Cash GenerationMaterial cash balances, revolver availability and improving operating cash flows give durable financial flexibility for opportunistic acquisitions, turnaround investments and capital needs. This liquidity buffer reduces refinancing risk and supports disciplined capital allocation over the medium term.
Bears Say
Margin Compression And Uneven Cash ConversionLower gross and EBITDA margins versus prior years and incomplete translation of profits into cash suggest structural cost or mix pressures. Persistent margin compression and sub‑optimal cash conversion limit reinvestment capacity and increase sensitivity to reimbursement shifts over months.
Leverage Volatility And Prior 2025 Debt SpikeMaterial year-to-year swings in leverage—highlighted by a 2025 debt spike—signal financing and execution risk if operating conditions worsen. Volatile leverage can constrain strategic optionality, raise borrowing costs and amplify downside in stressed scenarios across the medium term.
Medicaid And Reimbursement UncertaintyState Medicaid funding volatility and heightened payer scrutiny create durable reimbursement risk for a Medicare/Medicaid‑exposed operator. Prolonged payment changes, audits or delayed state budgets can depress revenue realization and cash flow for facilities reliant on public payors.
The Ensign Group News
EGB FAQ
What was The Ensign’s price range in the past 12 months?
The Ensign lowest stock price was €116.00 and its highest was €184.00 in the past 12 months.
What is The Ensign’s market cap?
The Ensign’s market cap is €8.75B.
When is The Ensign’s upcoming earnings report date?
The Ensign’s upcoming earnings report date is Jul 23, 2026 which is today.
How were The Ensign’s earnings last quarter?
Currently, no data Available
Is The Ensign overvalued?
According to Wall Street analysts The Ensign’s price is currently Undervalued.
Does The Ensign pay dividends?
The Ensign does not currently pay dividends.
What is The Ensign’s EPS estimate?
The Ensign’s EPS estimate is 1.62.
How many shares outstanding does The Ensign have?
The Ensign has 58,445,400 shares outstanding.
What happened to The Ensign’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of The Ensign?
Currently, no hedge funds are holding shares in DE:EGB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
The Ensign Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€189.07 (10.89% Upside)
€189.07 (10.89% Upside)
Blogger Sentiment
Bullish
DE:EGB Sentiment 70%
Sector Average 66%
Sector Average 66%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
24.61%
12-Months-Change
Fundamentals
Return on Equity
0.15%
Trailing 12-Months
Asset Growth
17.90%
Trailing 12-Months
Company Description
The Ensign
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.
EGB Stock 12 Month Forecast
Average Price Target
€189.07
▲(10.89% Upside)
Technical Analysis
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Surgery Partners
―








